Sickle Cell Disease

“A rare hereditary blood disorder that leads to a shortened life span and serious complications in many patients, including chronic iron overload in patients receiving blood transfusions.” – Novartis

In recent news, a new drug by Novartis for sickle-cell has been approved by the FDA.